Besides, endogenous IL-33 release, within 24 h, after administration of alum-adjuvanted nasal influenza vaccine, induced higher IgA Ab production via enhancing Ag presentation on DCs and promoting ILC2 activation44. The gene discussed is IL33; the disease is influenza.